2.08
                                            
            Mangoceuticals Inc stock is traded at $2.08, with a volume of 191.01K.
            It is up +1.46% in the last 24 hours and down -5.02% over the past month.
            Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
        
        See More
    Previous Close:
              $2.05
            Open:
              $2.05
            24h Volume:
                191.01K
            Relative Volume:
              0.97
            Market Cap:
                $23.44M
            Revenue:
              $516.00K
            Net Income/Loss:
              $-14.20M
            P/E Ratio:
              -0.6522
            EPS:
                -3.1891
            Net Cash Flow:
                $-5.83M
            1W Performance:
              -10.73%
            1M Performance:
              -5.02%
            6M Performance:
                +25.30%
            1Y Performance:
              -12.24%
            Mangoceuticals Inc Stock (MGRX) Company Profile
Name
                  
                      Mangoceuticals Inc
                    
                Sector
                  Industry
                  Phone
                  
                      (833) 626-4679
                    
                Address
                  
                      15110 DALLAS PKWY, SUITE 600, DALLAS
                    
                Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                MGRX
                            
                             Mangoceuticals Inc | 2.08 | 23.44M | 516.00K | -14.20M | -5.83M | -3.1891 | 
|   
                          
                                VEEV
                            
                             Veeva Systems Inc | 291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 | 
|   
                          
                                TEM
                            
                             Tempus Ai Inc | 89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 | 
|   
                          
                                DOCS
                            
                             Doximity Inc | 66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 | 
|   
                          
                                HQY
                            
                             Healthequity Inc | 94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 | 
|   
                          
                                WAY
                            
                             Waystar Holding Corp | 35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 | 
Mangoceuticals Inc Stock (MGRX) Latest News
Analyzing Mangoceuticals Inc. with risk reward ratio chartsEarnings Recap Report & Daily Growth Stock Tips - newser.com
Can Mangoceuticals Inc. stock sustain free cash flow growthJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - newser.com
How Mangoceuticals Inc. stock performs in weak economyWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
Why Mangoceuticals Inc. stock remains on buy listsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Can Mangoceuticals Inc. stock sustain revenue growthMarket Trend Summary & High Conviction Buy Zone Alerts - newser.com
Is Mangoceuticals Inc. stock safe for conservative investorsJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Can Mangoceuticals Inc. stock withstand economic slowdownMarket Performance Recap & AI Driven Stock Price Forecasts - newser.com
Visual analytics tools that track Mangoceuticals Inc. performanceTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Is Mangoceuticals Inc. stock gaining market share2025 Volatility Report & Low Drawdown Trading Techniques - newser.com
How to forecast Mangoceuticals Inc. trends using time seriesWeekly Loss Report & Consistent Return Investment Signals - newser.com
Is Mangoceuticals Inc. trending in predictive chart modelsJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
How to escape a deep drawdown in Mangoceuticals Inc.July 2025 Levels & Reliable Entry Point Alerts - newser.com
Can Mangoceuticals Inc. stock rebound after recent weaknessEarnings Summary Report & Free Community Consensus Stock Picks - newser.com
How Mangoceuticals Inc. stock performs after earnings2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Can technical indicators confirm Mangoceuticals Inc.’s reversalWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Will breakout in Mangoceuticals Inc. lead to full recoveryJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Can Mangoceuticals Inc. rally from current levels2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Mangoceuticals Inc. stock chart pattern explainedJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Can Mangoceuticals Inc. stock reach $100 price target2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
Mangoceuticals Signs Lease Agreement in Dallas - TipRanks
Full technical analysis of Mangoceuticals Inc. stockJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Why Mangoceuticals Inc. stock appeals to analystsJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará
Why retail investors favor Mangoceuticals Inc. stock2025 Top Decliners & Long-Term Growth Plans - Fundação Cultural do Pará
Can Mangoceuticals Inc. stock deliver surprise earnings beatWeekly Trend Report & Community Consensus Trade Signals - Fundação Cultural do Pará
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App